Therefore, in this study, not only did we find that A20 is a new substrate that is bound to- and phosphorylated by PKCδ, but also confirmed that excessive expression of A20 inhibits pulmonary inflammation and finally reduces IPF. Here, PRKCD is linked to idiopathic pulmonary fibrosis.